Jeil Pharm (002620) — Cash Flow Quality Index
Jeil Pharm (002620) has a Cash Flow Quality Index of 0.41x as of March 2026. Operating cash flow of ₩447.08 Million is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 002620 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jeil Pharm Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Jeil Pharm across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jeil Pharm (002620) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jeil Pharm (2011–2025)
Year-by-year earnings quality comparison for Jeil Pharm. For live market cap and the full company financial profile, see Jeil Pharm (002620) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₩390.26 Million | ₩14.64 Billion | ▲ +101.3% |
| 2020 | -2.07x | ₩-23.67 Billion | ₩11.43 Billion | ▼ -326.5% |
| 2018 | -0.49x | ₩-3.43 Billion | ₩7.07 Billion | ▼ -4365.5% |
| 2017 | 0.01x | ₩5.92 Billion | ₩520.35 Billion | ▼ -99.2% |
| 2016 | 1.44x | ₩11.36 Billion | ₩7.89 Billion | ▲ +412.1% |
| 2015 | 0.28x | ₩2.74 Billion | ₩9.76 Billion | ▲ +179.6% |
| 2012 | -0.35x | ₩-3.94 Billion | ₩11.17 Billion | ▼ -140.4% |
| 2011 | 0.87x | ₩23.63 Billion | ₩27.01 Billion | — |